0001140361-18-018375.txt : 20180412
0001140361-18-018375.hdr.sgml : 20180412
20180412164948
ACCESSION NUMBER: 0001140361-18-018375
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180412
DATE AS OF CHANGE: 20180412
EFFECTIVENESS DATE: 20180412
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-310058
FILM NUMBER: 18752535
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
D
1
primary_doc.xml
X0708
D
LIVE
0001314102
EyePoint Pharmaceuticals, Inc.
480 PLEASANT STREET
SUITE B300
WATERTOWN
MA
MASSACHUSETTS
02472
617-926-5000
DELAWARE
None
pSivida Corp.
pSivida LTD
Corporation
true
Nancy
Lurker
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Executive Officer
Director
President and Chief Executive Officer
David
Mazzo
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Director
Chairman of the Board of Directors
Michael
Rogers
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Director
Douglas
Godshall
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Director
James
Barry
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Director
Jay
Duker
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Director
Kristine
Peterson
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Director
Leonard
S.
Ross
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Executive Officer
Vice President, Finance and Chief Accounting Officer
Dario
Paggiarino
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Executive Officer
Vice President, Chief Medical Officer
Ronald
W.
Eastman
480 Pleasant Street
Suite B300
WATERTOWN
MA
MASSACHUSETTS
02472
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2018-03-28
false
true
true
true
false
0
600000
450000
150000
Pursuant to the terms of the warrant issued in the transaction, such warrant may become exercisable with respect to up to an additional $150,000 of shares of the Issuer's common stock upon the occurrence of certain events, set forth in the warrant.
false
1
0
0
0
false
EyePoint Pharmaceuticals, Inc.
/s/ Leonard S. Ross
Leonard S. Ross
Vice President, Finance and Chief Accounting Officer
2018-04-12